🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Preoprative Nebulized Dexmedetomidine Compared to Nebulized Lidocaine in Attenuating Sore Throat Following Tonsillectomy In Childern.

RecruitingNAAges 3 Years - 15 YearsFemaleFayoum University Hospital
NCT07780760 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to compare the effect of nebulized Dexmedetomidine compared to nebulized Lidocaine on postoperative sore throat in childern undergoing Tonsillectomy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age: Childern between 3:15 years old * American Society of Anesthesiologists(ASA) Physical Status I or II * Elective Tonsillectomy Exclusion Criteria: * Parents refusal * Presence of preoperative sore throat * Known allergy to the study drug * History of upper respiratory tract infection 2 weeks prior to surgery * Mental retardation or inability to communicate * Significant Cardiovascular disease as Heart Block * Post Tonsillectomy bleeding
💊

What it tests

  • Group D (dexmedetomidine group)
  • Group L (Lidocaine group)
📍

Where

1 site
Fayoum university Hospitl
Al Fayyum, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy